KD
Komala Devi Vankayalapati
About Komala Devi Vankayalapati
Data last updated:
Komala Devi Vankayalapati has 12 years in corporate governance. Holds Director role. Currently with 4 companies, including Arrien-Rajendra Spinning Mills Private Limited and New Line Medicines Private Limited. Formerly with 5 companies, such as Appcure Labs Private Limited. Engaged in General Business. Contributes to corporate operations. The 3 current companies with reported revenue have a combined latest revenue of ₹64.7 Lakh; the largest is Unitygrowth Investments Private Limited at ₹64.4 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Unitygrowth Investments Private Limited U65993TG2021PTC157318 | Director | 25 Nov 2021 | 2021 | ₹64.4 Lakh (FY 2025) | Active |
| New Line Medicines Private Limited U24100AP2016PTC098568 | Director | 19 Mar 2016 | 2016 | ₹13,700 (FY 2025) | Active |
| Arrien-Rajendra Spinning Mills Private Limited U17200TG2011PTC074738 | Director | 24 Aug 2022 | 2011 | ₹12,500 (FY 2025) | Active |
| Rxbridge Pharma Private Limited U46497TS2026PTC210111 | Director | 23 Jan 2026 | 2026 | – | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Appcure Labs Private Limited U24232TG2012PTC084625 | Whole-Time Director | 16 Aug 2014 | 2012 | ₹23.08 Cr (FY 2025) | Amalgamated |
| Alveus Pharmaceuticals Private Limited U24232TG2009PTC065531 | Director | 05 Jan 2022 | 2009 | ₹1.03 Cr (FY 2016) | Strike Off |
| Arrien Infrastructure India Private Limited U45200AP2010PTC071851 | Director | 05 Jan 2022 | 2010 | ₹37,000 (FY 2017) | Strike Off |
| Arrien Homes Private Limited U45209TG2013PTC086726 | Director | 16 Aug 2014 | 2013 | ₹21,100 (FY 2017) | Strike Off |
| Oros Pharmaceuticals Private Limited U73100TG2009PTC065273 | Director | 05 Jan 2022 | 2009 | – | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Komala Devi Vankayalapati
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Komala Devi Vankayalapati
Komala Devi Vankayalapati has 12 years in corporate governance. Holds Director role. Currently with 4 companies, including Arrien-Rajendra Spinning Mills Private Limited and New Line Medicines Private Limited. Formerly with 5 companies, such as Appcure Labs Private Limited. Engaged in General Business. Contributes to corporate operations. The 3 current companies with reported revenue have a combined latest revenue of ₹64.7 Lakh; the largest is Unitygrowth Investments Private Limited at ₹64.4 Lakh (FY 2025).
Komala Devi Vankayalapati is associated with 4 companies as Director, including Unitygrowth Investments Private Limited (₹64.4 Lakh), New Line Medicines Private Limited (₹13,700), Arrien-Rajendra Spinning Mills Private Limited (₹12,500).
Komala Devi Vankayalapati has expertise in General Business.
Komala Devi Vankayalapati has 12 years in corporate governance.
By reported revenue, the largest current company of Komala Devi Vankayalapati is Unitygrowth Investments Private Limited, with revenue of ₹64.4 Lakh (FY 2025).
The 3 current companies of Komala Devi Vankayalapati that report revenue have a combined latest revenue of ₹64.7 Lakh.
Komala Devi Vankayalapati currently holds positions at 4 companies: Unitygrowth Investments Private Limited (₹64.4 Lakh), New Line Medicines Private Limited (₹13,700), Arrien-Rajendra Spinning Mills Private Limited (₹12,500), Rxbridge Pharma Private Limited.